Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Background: Childhood acute myeloid leukemia (cAML) is the second most common pediatric blood cancer, with high heterogeneity and poor prognosis. Recent studies have highlighted cuproptosis, a newly ...

A team of researchers at Broad Institute of MIT and Harvard, in a long-term project that has included industry collaborators ...

The US Food and Drug Administration (FDA) has approved obecabtagene autoleucel, or obe-cel (AUTO1, Autolus Therapeutics) for the treatment of relapsed or refractory adult B-cell acute ...

In the ASC4FIRST trial, Scemblix showed superior MMR rates at week 48 compared to standard-of-care TKIs and imatinib alone. Credit: Elle Aon/Shutterstock. Novartis has received US Food and Drug ...

ELEVATED serum potassium levels usually result from deranged metabolic processes in renal or adrenal dysfunction whose detection often involves extensive laboratory investigation. Clinical and ...

I, John E. "Jack" Taylor of Columbia Falls, assumed a less sophisticated role in the carbon cycle on October 14, 2024. Several health issues ganged up on me when I was thinking about something else.

Many patients use cannabis to manage their cancer-related symptoms. However, research indicates that patients often do so without speaking to their oncologist first, and oncologists may be ...

myeloMATCH aims to help determine the best treatment options for AML and MDS patients more quickly. Credit: Kateryna Kon / Shutterstock. The US National Institutes of Health (NIH) has launched a ...

In a study published in Nature Cancer, the team showed that their compound binds to MCL1, removing its protective effects and ...